{"prompt": "['Serious Injury - An injury must meet the definition of \"serious injury\" in 21 CFR 803.3 for an', 'event to be reportable as a serious injury. A \"serious injury\" is an injury or illness that [21 CFR', '803.3]:', 'Is life threatening; or', 'Results in permanent impairment of a body function or permanent damage to a body', 'structure; or', 'Necessitates medical or surgical intervention to preclude permanent impairment of a', 'body function or permanent damage to a body structure.', '\"Permanent\" means irreversible impairment or damage to a body structure or function,', 'excluding trivial impairment or damage [21 CFR 803.3]. Note that not all cosmetic damage will', 'be considered trivial. Furthermore, a life-threatening injury meets the definition of serious', 'injury, regardless of whether the threat was \"temporary.\" It should also be noted that a device', 'does not have to malfunction for it to cause or contribute to a serious injury. Even though a', 'device may function properly, it can still cause or contribute to a death or serious injury.', '\"Malfunction\" means the failure of a device to meet its performance specifications or otherwise', 'perform as intended [21 CFR 803.3]. Performance specifications include all claims made in the', 'labeling for the device.', 'A malfunction is reportable if any one of the following is true:', 'The chance of a death or serious injury occurring as a result of a recurrence of the', 'malfunction is not remote;', 'The consequences of the malfunction affect the device in a catastrophic manner that', 'may lead to a death or serious injury;', 'The malfunction results in the failure of the device to perform its essential function', \"and compromises the device's therapeutic, monitoring or diagnostic effectiveness,\", 'which could cause or contribute to a death or serious injury or other significant', 'adverse device experiences required by regulation. (The essential function of a', \"device refers not only to the device's labeled use, but also to any use widely\", 'prescribed within the practice of medicine.);', 'The malfunction involves:', '- a long-term implant or', '- a device that is considered to be life-supporting or life-sustaining and thus is', 'essential to maintaining human life; or', 'The manufacturer takes, or would be required to take, an action under section 518 or', '519(g)10 of the FD&C Act as a result of the malfunction of the device or other', 'similar devices (see explanation of \"similar device\" below, and see section 2.21 of', 'this guidance for an explanation of \"remedial action\").', '10.8.', 'Definition of Serious Adverse Event', 'An SAE is any AE, occurring at any dose and regardless of causality that:', 'Page 40 of 101']['Results in death', 'Is life-threatening The patient is at immediate risk of death from the reaction as it', 'occurs. This does not include reaction that, had it occurred in a more severe form,', 'might have caused death.', 'Requires inpatient hospitalization or prolongation of existing hospitalization.', 'Hospital admission for elective surgery scheduled prior to study entry is not', 'considered an SAE.', 'Results in a persistent or significant incapacity or substantial disruption of the ability', 'to conduct normal life functions)', 'Is a congenital anomaly/birth defect', 'Important Medical Events that may not result in death, be life-threatening, or require', 'hospitalization may be considered serious AEs when, based upon appropriate', 'medical judgment, they may jeopardize the patient and may require medical or', 'surgical intervention to prevent one of the outcomes listed above.', '10.9.', 'Follow-up Information on a Serious Adverse Event', 'Appropriate diagnostic tests should be performed and therapeutic measures, as medically', 'indicated, should be instituted. Appropriate consultation and follow-up evaluations should be', 'carried out until the event has resolved or is otherwise explained by the Investigator. For all', 'SAEs, the Investigator will make at least two documented efforts for a follow up, when', 'necessary and provide information to Vascular Insights.', 'In addition, an Investigator may be requested by Vascular Insights to obtain specific', 'information in an expedited manner. This information may be more detailed than that captured', 'on the AE form. In general, this will include a description of the AE in sufficient detail to allow', 'for a complete medical assessment of the case and independent determination of possible', 'causality. Information on other possible causes such as concomitant medication and illnesses', 'must be provided. Event will be followed up until resolved.', '10.10.', 'Abnormal Test Findings', 'The criteria for determining whether an abnormal objective test finding should be reported as an', 'AE are as follows:', 'Test result is associated with accompanying symptoms that are considered clinically', 'significant in the opinion of the Investigator.', 'Test result requires additional diagnostic testing (other than merely repeating an', 'abnormal test) or medical/surgical intervention.', 'Test result leads to discontinuation from the study, significant additional concomitant', 'drug treatment, or other therapy.', 'Test result is considered an AE by the Investigator or Sponsor.', 'Page 41 of 101']\n\n###\n\n", "completion": "END"}